2012
Protein identification in biomarker discovery studies based on profiling of intact proteins: Why the challenge? Lesson gained from breast cancer tissues
BOUCHAL, Pavel; Monika DVOŘÁKOVÁ; Spiros D. GARBIS; Alexander SCHERL; Rudolf NENUTIL et al.Základní údaje
Originální název
Protein identification in biomarker discovery studies based on profiling of intact proteins: Why the challenge? Lesson gained from breast cancer tissues
Autoři
BOUCHAL, Pavel; Monika DVOŘÁKOVÁ; Spiros D. GARBIS; Alexander SCHERL; Rudolf NENUTIL a Bořivoj VOJTĚŠEK
Vydání
60th Conference on Mass Spectrometry and Allied Topics, 2012
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
10600 1.6 Biological sciences
Stát vydavatele
Kanada
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Označené pro přenos do RIV
Ne
Organizační jednotka
Přírodovědecká fakulta
Klíčová slova anglicky
top-down proteomics; FT-MS; MALDI; SELDI; 3D separation; breast cancer
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 4. 4. 2013 18:10, doc. Mgr. Pavel Bouchal, Ph.D.
Anotace
V originále
We showed thate the use of simple combination of protein/peptide separation technique followed by MS/MS leads to high uncertainty in protein biomarker identification in biomarker discovery studies based on profiling of intact proteins. This is given namely by the fact that database molecular weight of proteins does not reflect their posttranslational modifications. Here we propose two protocols to overcome these bottlenecks: (i) For proteins larger than 6 kDa, we have developed a method combining IMAC column preseparation, reverse phase LC, MALDI/SELDI protein profiling, tricine SDS-PAGE, protein profile matching, trypsin digestion and MS/MS identification. (ii) For identification of proteins smaller than 6 kDa, we have optimized a "top-down" procedure where tricine SDS-PAGE is replaced by LC-MS/MS of proteins on LTQ Orbitrap Velos with the use "no enzyme" option during MS/MS ion search. This protocol enabled and identification of HNRNP A2/B1 protein variant correlating with estrogen receptor expression in breast cancer.
Návaznosti
| GAP304/10/0868, projekt VaV |
|